Previous 10 | Next 10 |
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
2024-05-02 06:35:02 ET More on ITT ITT Inc. (ITT) Q4 2023 Earnings Call Transcript ITT Inc. 2023 Q4 - Results - Earnings Call Presentation ITT Q1 2024 Earnings Preview ITT Non-GAAP EPS of $1.34 in-line, revenue of $829.1M beats by $14.72M Seeking Alph...
13% orders growth (7% organic) driven by improved connectors demand, aerospace and defense components ramp, and Friction and rail share gains 14% revenue growth (9% organic), surpassing $900 million in revenue for the quarter, driven by higher volume in all businesses 80 basis poi...
2024-05-01 12:30:56 ET More on ITT ITT Inc. (ITT) Q4 2023 Earnings Call Transcript ITT Inc. 2023 Q4 - Results - Earnings Call Presentation ITT Non-GAAP EPS of $1.34 in-line, revenue of $829.1M beats by $14.72M ITT Q4 2023 Earnings Preview Seeking Alph...
April 25, 2024-- ITT Inc. (NYSE: ITT ) is proud to announce it has earned the designation of 3-Star Employer in the 2024 VETS Indexes Employer Awards, which evaluate employers’ policies, practices and outcomes in hiring and developing military community members. VETS Indexes is an inde...
2024-04-19 12:03:30 ET More on Merck Merck Earnings Preview: Not Much To Fear, Plenty To Look Forward To Merck: We Were Wrong, But The Exuberance Is Overly Done Here (Rating Upgrade) Merck: Better Times Ahead On Approvals And Outlook Moderna stock climbs 8% a...
April 16, 2024-- ITT Inc. (NYSE: ITT ) today announced its participation in Oppenheimer’s 19th Annual Industrial Growth Conference on Tuesday, May 7. Chief Financial Officer Emmanuel Caprais will present virtually from 11:15-11:50 a.m. ET on May 7. A live audio webcast of the prese...
2024-04-15 08:40:27 ET More on Viracta Therapeutics Seeking Alpha’s Quant Rating on Viracta Therapeutics Historical earnings data for Viracta Therapeutics Financial information for Viracta Therapeutics Read the full article on Seeking Alpha For...
April 11, 2024-- ITT Inc. (NYSE: ITT ) will release its first quarter 2024 financial results before the opening of the New York Stock Exchange on Thursday, May 2. The company will hold a conference call at 8:30 a.m. ET on May 2 to discuss its first quarter performance. To participate on t...
April 2, 2024-- ITT Inc. (NYSE: ITT ) today announced the nomination of Christopher O’Shea for election to its Board of Directors at the company’s upcoming 2024 annual meeting of shareholders. Mr. O’Shea currently serves as Chief Executive Officer (CEO) of UK-based Centri...
News, Short Squeeze, Breakout and More Instantly...
July 11, 2024-- ITT Inc. (NYSE: ITT ) today announced a strategic commercial agreement from its Svanehøj business, furthering the company’s leadership position in the green energy transition. Svanehøj, acquired in January 2024 by ITT, is a designer and manufacturer of special...
July 9, 2024-- ITT Inc. (NYSE: ITT ) will release its second quarter 2024 financial results before the opening of the New York Stock Exchange on Thursday, Aug. 1. The company will hold a conference call at 8:30 a.m. ET on Aug. 1 to discuss its second quarter performance. To participate on...
2024-06-19 00:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...